These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Protamine releases endothelium-derived relaxing factor from systemic arteries. A possible mechanism of hypotension during heparin neutralization. Pearson PJ; Evora PR; Ayrancioglu K; Schaff HV Circulation; 1992 Jul; 86(1):289-94. PubMed ID: 1617779 [TBL] [Abstract][Full Text] [Related]
3. Catastrophic cardiovascular adverse reactions to protamine are nitric oxide/cyclic guanosine monophosphate dependent and endothelium mediated: should methylene blue be the treatment of choice? Viaro F; Dalio MB; Evora PR Chest; 2002 Sep; 122(3):1061-6. PubMed ID: 12226053 [TBL] [Abstract][Full Text] [Related]
4. Role of heparin and nitric oxide in the cardiac and regional hemodynamic properties of protamine in conscious chronically instrumented dogs. Oguchi T; Doursout MF; Kashimoto S; Liang YY; Hartley CJ; Chelly JE Anesthesiology; 2001 Jun; 94(6):1016-25. PubMed ID: 11465593 [TBL] [Abstract][Full Text] [Related]
5. Relation of cyclic guanosine monophosphate and cyclic adenosine monophosphate in reducing the toxic effects of protamine administration. Katircioğlu SF; Taşdemir O; Bayazit K J Thorac Cardiovasc Surg; 1997 Mar; 113(3):617. PubMed ID: 9081115 [No Abstract] [Full Text] [Related]
6. Protamine sulfate causes endothelium-independent vasorelaxation via inducible nitric oxide synthase pathway. Takakura K; Mizogami M; Fukuda S Can J Anaesth; 2006 Feb; 53(2):162-7. PubMed ID: 16434757 [TBL] [Abstract][Full Text] [Related]
7. Methylene Blue to Treat Protamine-induced Anaphylaxis Reactions. An Experimental Study in Pigs. Albuquerque AA; Margarido EA; Menardi AC; Scorzoni A; Celotto AC; Rodrigues AJ; Vicente WV; Evora PR Braz J Cardiovasc Surg; 2016; 31(3):226-231. PubMed ID: 27737405 [TBL] [Abstract][Full Text] [Related]
8. Toward a better understanding of the hemodynamic effects of protamine and heparin interaction. Stefaniszyn HJ; Novick RJ; Salerno TA J Thorac Cardiovasc Surg; 1984 May; 87(5):678-86. PubMed ID: 6717047 [TBL] [Abstract][Full Text] [Related]
9. Protamine induces endothelium-dependent vasodilatation of the pulmonary artery. Evora PR; Pearson PJ; Schaff HV Ann Thorac Surg; 1995 Aug; 60(2):405-10. PubMed ID: 7646104 [TBL] [Abstract][Full Text] [Related]
10. Protamine after heparin produces hypotension resulting from decreased sympathetic outflow secondary to increased nitric oxide in the central nervous system. Hamada Y; Kameyama Y; Narita H; Benson KT; Goto H Anesth Analg; 2005 Jan; 100(1):33-37. PubMed ID: 15616048 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary microvascular responses to protamine and histamine. Effects of cardiopulmonary bypass. Friedman M; Johnson RG; Wang SY; Dai HB; Thurer RL; Weintraub RM; Sellke FW J Thorac Cardiovasc Surg; 1994 Dec; 108(6):1092-9. PubMed ID: 7983878 [TBL] [Abstract][Full Text] [Related]
12. Protamine-induced pulmonary venoconstriction in heparinized pigs. Hakim TS; Picone A; Oleary CE; Camporesi EM Anesth Analg; 1995 Jul; 81(1):38-43. PubMed ID: 7598279 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular actions of inhibitors of endothelium-derived relaxing factor (nitric oxide) formation/release in anesthetized dogs. Klabunde RE; Ritger RC; Helgren MC Eur J Pharmacol; 1991 Jun; 199(1):51-9. PubMed ID: 1893927 [TBL] [Abstract][Full Text] [Related]
14. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Balligand JL; Kelly RA; Marsden PA; Smith TW; Michel T Proc Natl Acad Sci U S A; 1993 Jan; 90(1):347-51. PubMed ID: 7678347 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine. Kilbourn RG; Gross SS; Lodato RF; Adams J; Levi R; Miller LL; Lachman LB; Griffith OW J Natl Cancer Inst; 1992 Jul; 84(13):1008-16. PubMed ID: 1376778 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular actions of NG-methyl-L-arginine are abolished in a canine shock model using high-dose endotoxin. Klabunde RE; Helgren MC Res Commun Chem Pathol Pharmacol; 1992 Oct; 78(1):57-68. PubMed ID: 1462049 [TBL] [Abstract][Full Text] [Related]
17. Stimulation of cyclic GMP production in cultured endothelial cells of the pig by bradykinin, adenosine diphosphate, calcium ionophore A23187 and nitric oxide. Boulanger C; Schini VB; Moncada S; Vanhoutte PM Br J Pharmacol; 1990 Sep; 101(1):152-6. PubMed ID: 2178013 [TBL] [Abstract][Full Text] [Related]
18. NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs. Kilbourn RG; Cromeens DM; Chelly FD; Griffith OW Crit Care Med; 1994 Nov; 22(11):1835-40. PubMed ID: 7956289 [TBL] [Abstract][Full Text] [Related]
19. Basal release of endothelium-derived nitric oxide plays an important role in the prevention of afterload mismatch in acute left ventricular dysfunction. Yamamoto K; Masuyama T; Mano T; Naito J; Kondo H; Nagano R; Tanouchi J; Hori M; Kamada T Angiology; 1995 Sep; 46(9):767-77. PubMed ID: 7661379 [TBL] [Abstract][Full Text] [Related]